GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $3.79 $5.28 Thursday, 18th Apr 2024 AVXL stock ended at $3.80. This is 6.63% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 7.65% from a day low at $3.79 to a day high of $4.08.
90 days $3.79 $6.90
52 weeks $3.79 $10.31

Historical Anavex Life Sciences Corp. prices

Date Open High Low Close Volume
2022-10-19 $12.13 $12.27 $11.05 $11.20 1 364 048
2022-10-18 $13.00 $13.34 $12.21 $12.29 1 482 884
2022-10-17 $11.07 $12.62 $11.06 $12.49 1 952 641
2022-10-14 $10.96 $11.11 $10.53 $10.60 663 361
2022-10-13 $10.28 $10.99 $10.06 $10.97 786 766
2022-10-12 $11.00 $11.17 $10.39 $10.57 588 091
2022-10-11 $10.30 $11.26 $10.16 $10.87 927 851
2022-10-10 $10.41 $10.52 $10.20 $10.33 530 723
2022-10-07 $10.86 $11.05 $10.48 $10.51 797 896
2022-10-06 $10.71 $11.15 $10.59 $11.03 640 888
2022-10-05 $10.70 $10.91 $10.45 $10.81 550 844
2022-10-04 $10.68 $10.90 $10.46 $10.89 872 012
2022-10-03 $10.59 $10.72 $10.24 $10.49 819 356
2022-09-30 $9.55 $10.66 $9.55 $10.32 1 047 417
2022-09-29 $10.15 $10.44 $9.65 $9.75 1 083 362
2022-09-28 $9.55 $10.60 $9.36 $10.45 1 610 976
2022-09-27 $9.06 $9.36 $8.93 $9.25 854 570
2022-09-26 $9.09 $9.49 $8.87 $8.90 665 760
2022-09-23 $9.28 $9.37 $8.91 $9.18 864 201
2022-09-22 $9.12 $9.51 $8.90 $9.34 787 535
2022-09-21 $9.58 $9.68 $9.16 $9.20 860 454
2022-09-20 $8.98 $9.27 $8.96 $9.20 709 241
2022-09-19 $9.13 $9.32 $8.90 $9.08 651 332
2022-09-16 $9.34 $9.40 $8.97 $9.25 1 177 280
2022-09-15 $9.50 $9.68 $9.26 $9.51 595 831
Click to get the best stock tips daily for free!

About Anavex Life Sciences Corp.

Anavex Life Sciences . Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinica... AVXL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT